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Otopalatodigital syndrome type 1 (OPD1) is an X-linked semidominant condition characterized by malformations
of the skeleton, auditory apparatus, and palate. Previous studies have established linkage to a 16-cM region of
Xq27-q28. A proposed allelic variant of OPD1, termed “OPD2,” is associated with a more severe, frequently lethal
phenotype with visceral and brain anomalies in addition to skeletal, auditory, and palatal defects. We report linkage
of the OPD2 phenotype to a 2-cM region of distal Xq28 in a Maori kindred, with a maximum multipoint LOD
score of 3.31 between the markers DXS1073 and DXS1108. This provides support for allelism between OPD1 and
OPD2 and reduces the size of the disease interval to 1.8–2.1 Mb. We also demonstrate that female carriers of this
disorder exhibit skewed inactivation that segregates with the high-risk haplotype and may be inversely related to
the severity with which they manifest features of the disorder.
Otopalatodigital syndrome type 1 (OPD1 [MIM
311300]) is an X-linked condition characterized, in
affected males, by skeletal abnormalities, conductive or
sensorineural hearing loss, and cleft palate (Taybi et al.
1962; Dudding et al. 1967). The skeletal dysplasia com-
prises camptodactyly, long spatulate fingers, pectus car-
inatum, mild campomelia, and malformed auditory os-
sicles—the latter feature leading to conductive hearing
loss in some individuals. Carrier females may exhibit the
same manifestations as males but generally have amilder
range of expressivity. A second entity—comprising a
more severe skeletal dysplasia, cleft palate, and micro-
gnathia—was subsequently described (Fitch et al. 1976)
and was later designated “otopalatodigital syndrome
type 2” (OPD2 [MIM 304120]), owing to its clinical
similarity to OPD1 (Fitch et al. 1983). Subsequent re-
ports have extended the phenotype of OPD2 to include
cardiac, genitourinary, gastrointestinal, and central nerv-
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ous system anomalies. Perinatal death is common be-
cause of these malformations, and intellectual disability
sometimes occurs, in contrast to OPD1. As in OPD1,
carrier females with OPD2 exhibit a phenotype that can
extend from a mild subclinical osteodysplasia to a pre-
sentation indistinguishable from that of affected males.
Two studies have previously linked OPD1 to the distal
portion of the long arm of the X chromosome, between
DXS539 (located in Xq27) and the telomere—a distance
of 16 cM (Biancalana et al. 1991; Hoar et al. 1992). No
linkage studies have previously been performed on
OPD2, and, therefore, no experimental evidence exists
to support the clinical hypothesis that these two disor-
ders are allelic.
We have previously ascertained a four-generation fam-
ily of Maori ancestry from New Zealand that segregates
OPD2 (Robertson et al. 1997). Several individuals have
been born since the original report, and the updated
pedigree is presented in figure 1. Within this family, there
have been five affected males, all of whom died peri-
natally and had a severe skeletal dysplasia with cam-
pomelia, thoracic constriction, and digital anomalies.
Three of these individuals had an omphalocele, two had
cleft palate, and four had genitourinary anomalies. An
additional male (III-1) died perinatally of unknown
cause. Six females could be identified as carriers, either
because they had transmitted the mutant allele (four sub-
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Figure 1 Pedigree of the family segregating for OPD2. Unblackened circle, unaffected female; gray circle, subclinically affected female;
blackened circles, clinically manifesting female; and blackened square, affected male. Haplotypes are depicted for markers located in the distal
region of Xq, and the segment that segregates perfectly with the disease is boxed. Individual III-8 is known to have a different father from her
female siblings. Genotypes for the locus BGN represent a combination of results obtained from DXSBGN and the novel SNP identified in
intron 5. The locus 2–19 is a novel marker identified as polymorphic during the course of this study (see text). The position of the key
recombination in individual IV-4 is indicated with a cross. The results for clinically unaffected females in generation IV are omitted, to avoid
revealing their carrier status.
jects), because they manifested specific features of OPD2
(one subject), or for both reasons (one subject). The spe-
cific manifestations were conductive deafness caused by
malformed auditory ossicles (III-8) and bilateral hearing
loss, cleft palate, spatulate fingers, and a chest wall de-
formity (IV-7). The four apparently healthy carriers ex-
hibited minor, but consistent, radiological anomalies of
the skull base, ribs, vertebral bodies, and long bones.
The study was approved by the local institutional ethics
committee, and informed consent was given to obtain
venous blood, from all available members of the ped-
igree, and fixed tissue, from autopsy specimens of
IV-3 and IV-12. DNA was prepared using standard
techniques.
Given the established clinical and pedigree evidence
that OPD2 segregates as an X-linked trait, the segre-
gation of a panel of polymorphic markers encompassing
the entire X chromosome (Dib et al. 1996) was studied
in this family. The data were analyzed using the MLINK
and LINKMAP programs from the FASTLINK 4.0 soft-
ware package (Lathrop and Lalouel 1984; Cottingham
et al. 1993; Scha¨ffer et al. 1994), available through the
U.K. Human Genome Mapping Project, to obtain two-
point and multipoint LOD scores, respectively. The trait
was assigned as X linked, with the penetrance of the
disease allele set at 1.0 and with the disease-allele fre-
quency set at .0001. All males and the six females iden-
tified as carriers were included in the calculation of the
LOD score.
The only markers that yielded significantly positive
LOD scores mapped to distal Xq28. MarkersDXS1073
and DXS1108, located 1.5 Mb and 0.5 Mb from the
telomere, respectively, gave two-point LOD scores of
2.41 and 2.71, respectively, at . Bymultipoint anal-vp 0
ysis, a maximum LOD score of 3.31 was obtained be-
tween markers DXS1073 and DXS1108 (fig. 2). Local-
ization to any other region of the X chromosome was
excluded, at odds of 1100:1 (data not shown). This
confirmed that the OPD2 phenotype in this family maps
to the same region of the X chromosome as does OPD1,
consistent with allelism of the two conditions.
Inspection of haplotypes identified a recombination at
DXS8103 in the unaffected male IV-4, placing the dis-
ease locus distal to this marker (fig.1). We evaluated
BGN, which maps distal to DXS8103 and encodes the
proteoglycan biglycan, as a candidate disease gene
(Fisher et al. 1991). However, we identified a previously
undescribed single-nucleotide polymorphism (SNP)
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Figure 2 Multipoint LOD analysis of the family, in the region of the Xq telomere
Figure 3 Physical map outlining the position and extent of the candidate interval containing the gene mutated in OPD2
(IVS590CrT), for which IV-4 had inherited the same
allele that was found in affected individuals IV-3 and
IV-7, excluding BGN as the disease gene and placing
the disease gene distal to this locus (fig. 1).
To refine the linkage interval more precisely, we
searched published sequences within the region bounded
by BGN and DXS1073, for repetitive sequences and
SNPs. No published SNP or polymorphism was hetero-
zygous in III-5, but we identified three novel polymor-
phisms that were informative for the critical meiosis. An
(AT)n repeat was positioned 5
′ to the gene 2-19, which
is located 1.6 Mb from the telomere, and was amplified
with the primers 5′-GCAACAAAGTGAGACCCTGC-3′
and 5′-GTTGGCTGTGTCAGGTCAGG-3′ (GenBank
L44140). The second locus, a polyadenine stretch located
adjacent to the TKTL1 gene 1.8 Mb from the telomere,
was amplified with the primers 5′-CGTGGTGGCTTAC-
ACCTGTC-3′ and 5′-ATACCTGCTTTCGTCGGGGCA-
CAC-3′ (GenBank Z49258). Both these loci were shown
to be nonrecombinant in the unaffected male (IV-4). The
disease allele at locus 2-19 originated from the unaffected
great-grandfather, I-1, indicating that the mutation arose
de novo in patient II-1 (fig. 1). A locus comprising a com-
plex repeat stretching over ∼350 bp, lying 1.5 kb 3′C Tn n
to the L1CAM gene (GenBank U52112), was also iden-
tified as polymorphic. This repeat was amplified initially
using the primers 5′-AAGTTCTCACCTTGAAAGTG-
CAG-3′ and 5′-GTAAAAAAATCAGGTTGCAGCG-3′
and was followed by a second reaction employing primers
5′-AAGTGGAGGGCTCACCTGTG-3′ and 5′-CGACA-
GAGCGAGACAAAGAAAG-3′. The two alleles in pa-
tient III-5 differed in length by a single CT dinucleotide
within the repeat, and individual IV-4 was recombinant
at this locus. This analysis reduced the OPD2 interval to
a maximum of 2.1 Mb (L1CAM–Xqter) and a minimum
of 1.8 Mb (TKTL1–Xqter) (fig. 3).
The terminal 2.1 Mb of Xq has been intensively stud-
ied, and much of it is sequenced and characterized in
terms of its gene content. Mutations in 12 genes are
known to cause specific monogenic disorders, and many
additional diseases map to this general region. The den-
sity of genes within the candidate interval is uneven;
gene-dense segments are found within the proximal 500
kb, but more-distal sequences have been predicted to be
relatively gene poor (De Sario et al. 1996). The 400 kb
bounded by the telomere, termed the “Xq/Yq homology
region,” is fully sequenced and encodes four genes and
one pseudogene (Ciccodicola et al. 2000). Although all
four genes have counterparts on the homologous portion
of the Y chromosome, some are inactivated in a Y-spe-
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Figure 4 Skewing of X inactivation (relative methylation of al-
leles at the androgen-receptor locus) in relation to affection status of
females in the pedigree. Each symbol marks the mean of three inde-
pendent experiments, with the range of values obtained shown by a
vertical bar. Definitions of symbols are the same as in figure 1, except
that two individuals in generation IV, predicted by linkage analysis to
be carriers, are represented by gray symbols.
cific manner. This, together with the substantially lower
recombination rate compared to that observed for the
primary pseudoautosomal region at Xp/Yp, means that
these genes remain potential candidates for a disorder
such as OPD.
The linkage of OPD2 to a narrow region within the
candidate interval previously identified for OPD1 pro-
vides the first experimental support for the hypothesis
that the two conditions are allelic. Clinical evidence
exists to suggest that two other conditions, frontome-
taphyseal dysplasia (FMD [MIM 305620]) andMelnick-
Needles syndrome (MNS [MIM 309350]) may also be
allelic to OPD types 1 and 2 (Verloes et al. 2000). FMD
segregates as an X-linked semidominant condition and
is characterized by skull hyperostosis, digital/skeletal
anomalies, and deafness and is therefore reminiscent of
OPD1 (Superti-Furga and Gimelli 1987). Affected males
born to women with MNS bear striking resemblance to
males with OPD2 (Verloes et al. 2000). It is therefore
possible that the 1.8–2.1-Mb region that we have iden-
tified as the candidate interval for OPD2 contains the
gene mutated in all four conditions.
To gain further insight into the expression of the
OPD2 disease phenotype in carrier females, we per-
formed X-inactivation studies on DNA extracted from
peripheral blood samples. The relative methylation (and,
hence, inactivation) of the two alleles of the androgen-
receptor CAG repeat was measured by quantifying each
allele after digestion of the radiolabeled PCR product
by the restriction enzymeHpaII (Allen et al. 1992). Band
intensity was captured on a phosphoimager screen and
was integrated using IMAGEQUANT software, version
5.1 (Molecular Dynamics). Two of the four obligate car-
riers with only subclinical evidence of their carrier status
were informative in this assay and demonstrated 190%
inactivation of one allele in blood leucocytes (fig. 4).
Individual IV-7, who has a cleft palate, deafness, and
moderately severe skeletal findings, was less skewed
(80% inactivation of one allele). Individual III-8 with
conductive deafness caused by ossicular deformities was
uninformative. Two other females in generation IV, who
are clinically normal but have not been examined radio-
logically, are predicted, by linkage analysis, to carry the
mutant allele and were also noted to be 190% skewed.
Two females (I-2 and another in generation IV), pre-
dicted, by linkage analysis, to be noncarriers demon-
strated a randomX-inactivation pattern (68% and 71%,
respectively).
The preponderance of severely skewed individuals in
this family is well in excess of the proportion observed
in the general population (Sharp et al. 2000). Moreover,
skewed X inactivation cosegregates with the OPD2 and
high-risk haplotype. The most likely explanation for
these observations is that, in carrier females, selection
occurs early in embryogenesis, against cells in which the
active X chromosome bears the mutant allele, as is doc-
umented in several other X-linked disorders (Migeon
and Haisley-Royster 1998).
The manifesting female IV-7 showed a less dramati-
cally skewed pattern of X inactivation. Variation in the
severity of the female phenotype has been described for
both OPD1 (Gall et al. 1972; Gorlin et al. 1973) and
OPD2 (Robertson et al. 1997), and these data suggest
that variation in the degree of X inactivation may be
responsible for these observations, as has been proposed
for the X-linked dominant condition Rett syndrome
(Amir et al. 2000). Once the causative gene is identified,
study of a larger group of unrelated male and female
patients with OPD and of its allelic conditions will allow
description not only of genotypic but also of epigenetic
influences, such as X inactivation, on the phenotypic
spectrum observed in these syndromes.
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